Tolerogenics 

Hydrogel Allergy Immune therapy

OWNER

Hannes De Wachter (See Profile)


Sector

Immunology

Stage

In vitro, proof of concept

Country

Luxembourg


Our hydrogels allow 1-step administration of therapeutic compositions

Our hydrogels provide sustained release of allergens and tolerogenic adjuvants (e.g. CpG oligos) for at least 2-3 days

Our hydrogels eliminate triggering of TH2- or TH1-immune responses

Our hydrogels are non-toxic and biodegradable, approved by FDA for human use

Tolerogenics holds several patents and patent applications in the field of immuotherapies based on tolerance induction.

This information is confidential, do not share or copy.

You can visit their website or

Download the Pitch Deck

Under evaluation at least till: 21rst of September

If you want to have more information or you want to review the project, you have to login or register

KEEP REVIEWING

©2023 BioExpert Network

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

ACEPTAR
Aviso de cookies

Log in with your credentials

or    

Forgot your details?

Create Account

Skip to toolbar